Cash Flow Statement
Growth Metrics

SRx Health Solutions (SRXH) Debt to Equity (2016 - 2025)

SRx Health Solutions' Debt to Equity history spans 12 years, with the latest figure at $1.23 for Q3 2025.

  • For Q3 2025, Debt to Equity rose 1692.89% year-over-year to $1.23; the TTM value through Sep 2025 reached $1.23, up 1692.89%, while the annual FY2025 figure was $1.23, N/A changed from the prior year.
  • Debt to Equity reached $1.23 in Q3 2025 per SRXH's latest filing, up from -$0.13 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $2.79 in Q1 2024 to a low of -$0.17 in Q1 2021.
  • Average Debt to Equity over 5 years is $0.38, with a median of $0.1 recorded in 2022.
  • Peak YoY movement for Debt to Equity: tumbled 171.85% in 2023, then surged 1692.89% in 2025.
  • A 5-year view of Debt to Equity shows it stood at $0.09 in 2021, then surged by 468.26% to $0.53 in 2022, then skyrocketed by 229.51% to $1.75 in 2023, then tumbled by 102.16% to -$0.04 in 2024, then skyrocketed by 3340.31% to $1.23 in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Debt to Equity are $1.23 (Q3 2025), -$0.13 (Q2 2025), and $0.15 (Q1 2025).